INR 81.4
(3.97%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 186.52 Million INR | -14.07% |
2022 | 217.06 Million INR | -31.93% |
2021 | 318.91 Million INR | 48.13% |
2020 | 215.29 Million INR | -64.9% |
2019 | 613.3 Million INR | 260.57% |
2018 | 170.09 Million INR | 34.57% |
2017 | 126.4 Million INR | 38.65% |
2016 | 91.16 Million INR | 12.22% |
2015 | 81.23 Million INR | -24.01% |
2014 | 106.89 Million INR | 35.22% |
2013 | 79.05 Million INR | 29.87% |
2012 | 60.87 Million INR | -36.81% |
2011 | 96.32 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -3.01 Billion INR | -1715.25% |
2023 Q3 | - INR | -100.0% |
2023 FY | 186.52 Million INR | -14.07% |
2023 Q4 | 186.52 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 408.33 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 217.06 Million INR | 0.0% |
2022 FY | 217.06 Million INR | -31.93% |
2022 Q2 | 331.86 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 318.91 Million INR | 48.13% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 291.35 Million INR | 0.0% |
2021 Q4 | 318.91 Million INR | 0.0% |
2020 Q4 | 215.29 Million INR | 0.0% |
2020 FY | 215.29 Million INR | -64.9% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 325.06 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q2 | 457.24 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 613.3 Million INR | 260.57% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 613.3 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q4 | 170.09 Million INR | 0.0% |
2018 FY | 170.09 Million INR | 34.57% |
2018 Q2 | 108.66 Million INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q4 | 126.4 Million INR | 0.0% |
2017 FY | 126.4 Million INR | 38.65% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 139.98 Million INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2016 Q4 | 91.16 Million INR | 0.0% |
2016 FY | 91.16 Million INR | 12.22% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 171.2 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 FY | 81.23 Million INR | -24.01% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 138.9 Million INR | 0.0% |
2015 Q4 | 81.23 Million INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 106.89 Million INR | 35.22% |
2014 Q4 | 106.89 Million INR | 0.0% |
2014 Q2 | 57.62 Million INR | 0.0% |
2013 Q2 | 61.94 Million INR | 0.0% |
2013 FY | 79.05 Million INR | 29.87% |
2013 Q4 | 79.05 Million INR | 0.0% |
2012 Q4 | 60.87 Million INR | 0.0% |
2012 FY | 60.87 Million INR | -36.81% |
2012 Q2 | 71.51 Million INR | 0.0% |
2011 Q4 | 96.32 Million INR | 0.0% |
2011 FY | 96.32 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ador Multiproducts Limited | 28.52 Million INR | -553.835% |
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | 83.04% |
Bajaj Consumer Care Limited | 1.53 Billion INR | 87.809% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 98.589% |
Dabur India Limited | 48.19 Billion INR | 99.613% |
Emami Limited | 8.21 Billion INR | 97.731% |
Gillette India Limited | 8.59 Billion INR | 97.83% |
Godrej Consumer Products Limited | 58.97 Billion INR | 99.684% |
Hindustan Unilever Limited | 270.76 Billion INR | 99.931% |
Hipolin Limited | 48.57 Million INR | -284.012% |
Honasa Consumer Limited | 5.36 Billion INR | 96.525% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | 31.35% |
Jyothy Labs Limited | 5.9 Billion INR | 96.842% |
Kaya Limited | 5.22 Billion INR | 96.428% |
Marico Limited | 32.52 Billion INR | 99.426% |
N.K Industries Limited | 22.4 Billion INR | 99.167% |
PAOS INDUSTRIES LIMITED | 163.96 Million INR | -13.757% |
Paramount Cosmetics (India) Limited | 205.72 Million INR | 9.332% |
Pee Cee Cosma Sope Limited | 80.17 Million INR | -132.637% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 98.279% |